PPARGC1A and cardiomyopathy: In mice, both too little and too much PGC-1α are detrimental. PGC-1α knockout leads to cardiomyopathy [12], but forced overexpression of PGC-1α at supraphysiologic levels induces uncontrolled mitochondrial proliferation and cardiomyopathy [12].